Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Chronic hepatitis. Aetiology and current management.

W G Cooksley, R A Bradbear, J W Halliday

    Drugs
    |June 1, 1984
    PubMed
    Summary

    Chronic hepatitis treatment remains complex, with autoimmune, hepatitis B, and non-A, non-B (NANB) types requiring distinct approaches. Understanding viral markers and developing NANB assays are key to solving chronic hepatitis enigmas.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Arthropathy in hereditary haemochromatosis segregates with elevated erythrocyte mean corpuscular volume.

    Scandinavian journal of rheumatology·2020
    Same author

    Concentrations of transferrin and carbohydrate-deficient transferrin in postmortem human brain from alcoholics.

    Addiction biology·2016
    Same author

    Boron based separations for in situ recovery of L-erythrulose from transketolase-catalyzed condensation.

    Biotechnology and bioengineering·2008
    Same author

    Patient-focused outcomes following detection in a hospital-based screening programme for C282Y haemochromatosis.

    Internal medicine journal·2008
    Same author

    Use of community genetic screening to prevent HFE-associated hereditary haemochromatosis.

    Lancet (London, England)·2005
    Same author

    HFE gene and hemochromatosis.

    Journal of gastroenterology and hepatology·2004

    Area of Science:

    • Hepatology
    • Immunology
    • Virology

    Background:

    • Chronic hepatitis presents diagnostic and therapeutic challenges, necessitating exclusion of specific causes like drugs, Wilson's disease, and alpha-1-antitrypsin deficiency.
    • Post-exclusion, chronic hepatitis is categorized into autoimmune, hepatitis B, and non-A, non-B (NANB) types, all with immunological underpinnings.
    • Autoimmune hepatitis is histologically subtyped into chronic persistent and chronic active hepatitis.

    Purpose of the Study:

    • To review the current understanding and treatment strategies for different forms of chronic hepatitis.
    • To highlight the immunological basis of chronic hepatitis pathogenesis.
    • To discuss advancements in diagnosing and managing hepatitis B and the challenges in NANB hepatitis.

    Main Methods:

    • Literature review of studies on chronic hepatitis classification and treatment.
    • Analysis of diagnostic criteria and therapeutic interventions for autoimmune hepatitis, hepatitis B, and NANB hepatitis.
    • Examination of serological markers, molecular probes (HBV-DNA), and viral co-infections in hepatitis B.

    Main Results:

    • Corticosteroids are indicated for chronic active hepatitis with cirrhosis or bridging necrosis, but contraindicated in hepatitis B virus infection.
    • Hepatitis B virus (HBV) infection management involves antiviral agents and immunomodulation, especially when viral replication is evident (e antigen, DNA polymerase, HBV-DNA positive).
    • Non-A, non-B (NANB) hepatitis remains poorly understood due to the lack of a specific assay, suggesting potential for multiple causative agents.

    Conclusions:

    • Effective management of chronic hepatitis depends on accurate etiological classification and tailored treatment strategies.
    • Advances in understanding hepatitis B, including serological markers and molecular probes, have significantly improved knowledge.
    • Development of an assay for NANB hepatitis is anticipated to resolve remaining enigmas in chronic hepatitis research.

    Related Experiment Videos